Pfizer Bags a New Biosimilar — and a Former Commissioner

In a big week for Pfizer, the world’s second largest drugmaker earned the FDA’s approval for a biosimilar cancer treatment and signed up the agency’s former Commissioner Scott Gottlieb for its board.
Source: Drug Industry Daily